GPAM-VTI1A Fusion FISH Probe
The GPAM-VTI1A Fusion FISH Probe is used to confirm a fusion of the GPAM and VTI1A genes. The fusion of the GPAM and VTI1A genes has been associated with Colon Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| GPAM-VTI1A-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-RERE | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-REOR | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-REGO | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-REGR | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-OROR | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-GORE | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-GROR | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| GPAM-VTI1A-20-AQAQ | 20 (40 μL) | 200 μL |
|
GPAM Gene Summary
This gene encodes a mitochondrial enzyme which prefers saturated fatty acids as its substrate for the synthesis of glycerolipids. This metabolic pathway's first step is catalyzed by the encoded enzyme. Two forms for this enzyme exist, one in the mitochondria and one in the endoplasmic reticulum. Two alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2011]
Gene Name: Glycerol-3-phosphate Acyltransferase, Mitochondrial
Chromosome: CHR10: 113909621 -113943525
Locus: 10q25.2
VTI1A Gene Summary
The protein encoded by this gene is a member of the family of soluble N-ethylmaleimide-sensitive fusion protein-attachment protein receptors (SNAREs) that function in intracellular trafficking. This family member is involved in vesicular transport between endosomes and the trans-Golgi network. It is a vesicle-associated SNARE (v-SNARE) that interacts with target membrane SNAREs (t-SNAREs). Polymorphisms in this gene have been associated with binocular function, and also with susceptibility to colorectal and lung cancers. A recurrent rearrangement has been found between this gene and the transcription factor 7-like 2 (TCF7L2) gene in colorectal cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Gene Name: Vesicle Transport Through Interaction With T-SNAREs 1A
Chromosome: CHR10: 114206755 -114578504
Locus: 10q25.2
Gene Diseases
The GPAM VTI1A Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Colon Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|